PET/CT in Resectable Non-Small Cell Lung Cancer

PET/CT in Resectable Non-Small Cell Lung Canc...

Up next

MRI for Active Surveillance in Prostate Cancer

In this episode, host Dr. Refky Nicola speaks with Dr. Francesco Giganti and Dr. Alex Kirkham about how MRI is used to guide active surveillance in prostate cancer, including the role of PRECISE scoring in tracking disease progression. They share practical insights on imaging tec ...  Show more

Evolving Strategies for Renal Cell Carcinoma

Dr. Ashwin Singh Parihar sits down with Dr. Iben Lyskjær and Dr. Tommy Kjærgaard Nielsen to unpack new nationwide registry data comparing ablation and surgical approaches for small renal masses. Together, they explore how minimally invasive treatments stack up in real-world pract ...  Show more

Recommended Episodes

Ep. 172 HPV and Oropharyngeal Cancer: Evolving Insights and Implications with Dr. Mihir Patel
BackTable ENT & Allergy

In this episode, Dr. Mihir Patel, Professor of Otolaryngology at Emory University and expert in Transoral Robotic Surgery (TORS), discusses HPV-positive head and neck cancer with host Dr. Ashley Agan. --- CHECK OUT OUR SPONSOR Medtronic ENT https://www.medtronic.com/en-us/healthc ...  Show more

#267 ‒ The latest in cancer therapeutics, diagnostics, and early detection | Keith Flaherty, M.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscri ...

  Show more

Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced NSCLC
CHEST Journal Podcasts

CHEST December 2021, Volume 160, Issue 6 Gerard A. Silvestri, MD, FCCP, and Adam H. Fox, MD, join CHEST Podcast Moderator Dominique Pepper, MD, to discuss the current knowledge and practice of pulmonologists regarding biomarker testing and targeted therapies in advanced non-small ...  Show more

Key Abstracts in GU Cancers at ASCO24
ASCO Daily News

Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss promising combination therapies and other compelling advances in genitourinary cancers in advance of the 2024 ASCO Annual Meeting.

<span style= "text-decoration: underline;">TRANSCRIPT</span>

  Show more